Lina Canamaque-Garcia

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Feasibility of Three-Dimensional Imaging in Accurately Assessing the Peritoneal Cancer Index for Peritoneal Carcinomatosis.

Feasibility of Three-Dimensional Imaging in Accurately Assessing the Peritoneal Cancer Index for Peritoneal Carcinomatosis.

Journal: Surgical innovation
Published: June 09, 2026

Sacral Neurolymphomatosis: Resolving a Clinical Enigma with 18F-FDG PET/MRI.

Sacral Neurolymphomatosis: Resolving a Clinical Enigma with 18F-FDG PET/MRI.

Journal: Revista espanola de medicina nuclear e imagen molecular
Published: March 02, 2026

Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?

Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?

Journal: The oncologist
Published: January 19, 2026

Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?

Can clinicians predict individual patient outcomes in neuroendocrine tumors treated with [177Lu]Lu-DOTATATE?

Journal: The oncologist
Published: January 19, 2026

Apathy linked to higher amyloid burden and cognitive deterioration in Parkinson's disease.

Apathy linked to higher amyloid burden and cognitive deterioration in Parkinson's disease.

Journal: Journal of Parkinson's disease
Published: September 17, 2025

Apolipoprotein E genotypes and amyloid burden associated with cognitive decline in non-demented Parkinson's disease patients: A preliminary analysis.

Apolipoprotein E genotypes and amyloid burden associated with cognitive decline in non-demented Parkinson's disease patients: A preliminary analysis.

Journal: Journal of the neurological sciences
Published: August 29, 2024

Prospective study on stereotactic body radiotherapy for small pancreatic neuroendocrine tumors: tolerance and effectiveness analysis.

Prospective study on stereotactic body radiotherapy for small pancreatic neuroendocrine tumors: tolerance and effectiveness analysis.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 12, 2024

Nigrostriatal blood-brain barrier opening in Parkinson's disease.

Nigrostriatal blood-brain barrier opening in Parkinson's disease.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: November 10, 2023

Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease.

Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease.

Journal: Journal of neuroimaging : official journal of the American Society of Neuroimaging
Published: July 14, 2023

[18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study.

[18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study.

Journal: European journal of nuclear medicine and molecular imaging
Published: May 18, 2023

BBB opening with focused ultrasound in nonhuman primates and Parkinson's disease patients: Targeted AAV vector delivery and PET imaging.

BBB opening with focused ultrasound in nonhuman primates and Parkinson's disease patients: Targeted AAV vector delivery and PET imaging.

Journal: Science advances
Published: April 19, 2023

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study.

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study.

Journal: European journal of nuclear medicine and molecular imaging
Published: December 06, 2022
Showing 1-12 of 28

Last Updated: 09/26/2026